Greater scrutiny of drugs planned
The Food and Drug Administration is launching an effort meant to strengthen its oversight of prescription drugs after they win approval, an agency official said.
The plan, called “Safety First,” includes creation of a new database of possible side effects from medicines. It also would establish clear schedules for following up on concerns about them.
The action is the FDA’s latest move to address allegations that the agency has been slow to respond to potential side effects that emerge after a medicine reaches the market.
The new plan will grant some new powers to the office that monitors the safety of medicines after their approval.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
